Information by product and service
Metabolomics is a branch of the omics sciences that deals with the study of biochemical processes, which involves the study of intermediates and by-products of metabolic activities. These products of metabolic pathways are called metabolomes, which include the group of all metabolites involved in various bodily functions such as metabolic intermediates, signaling molecules, secondary metabolites, and hormones.
Scientifically, a metabolomic study involves various analytical techniques (spectroscopy, chromatography and bioinformatics) and statistical tools (multivariate analysis for the determination and study of metabolites). The study of these metabolites can help in a wide range of applications, such as substantial equivalence testing, phenotyping of genetically modified plants, identification of gene function, and study of the biotic stress response. -abiotic.
The global Metabolomics market was valued at USD 1,674 million in 2019 and is expected to grow at a CAGR of 13.5% during the forecast period.
The Potential of Metabolomic Techniques in Therapeutics to Drive Market Growth
Over the past decade, metabolomics has gained ground due to its capabilities in disease biology research. Numerous studies have revealed that the optimal level of specific metabolites may be associated with the onset / progression of diseases. Metabolomic studies can be used to understand the response to treatment of these metabolite related diseases.
Request sample report: https://straitsresearch.com/report/metabolomics-market/request-sample
With the rapidly increasing prevalence and chronic diseases associated with lifestyle, such as cancer and cardiovascular disease, researchers are redoubling their efforts to develop new therapeutic approaches using metabolomic tools. In addition, it allows researchers and scientists to estimate physiological effects and monitor side effects of drugs. Thus, many pharmaceutical and biotechnology companies, research institutes have enormous capital for metabolomic research.
As reported by the Metabolomics Innovation Center (TMIC), metabolomics research has grown tremendously over the past decade. Thus, this heavy usage has enabled the market to achieve steady growth during the forecast period.
Growing awareness and funding from government and private authorities are fueling market growth
The metabolomics market has large-scale applications in many areas. The notable research improvements supported by market products and tools have raised awareness and supported several governments and private funding authorities around the world. Thus, the market has seen an increase in financing opportunities recently, which positively influences the growth of the market.
According to the National Institute of Health (NIH), in 2018, the United States had invested more than $ 65 million in Regional Comprehensive Metabolomics Resource Cores. According to the Metabolomics Innovation Center, Strategy Plan 2019-2024, Canada has invested more than US $ 30 million to advance research infrastructure and stimulate metabolomics research.
In January 2021, the National Institute of Health (NIH) funded the University of Massachusetts with a four-year project with $ 1.37 million, to advance the analysis of data-driven metabolomics research. Thus, the increasing investment and support in metabolomics research is fueling the uptake of market products and ultimately driving the market growth.
The Metabolomics Instruments segment accounts for the largest market share
On the basis of products and services, the Metabolomics Instruments segment is expected to account for the largest market share. Market dominance is due to technological advancements in analytical instruments, such as increased efficiency, process automation and computerization, coupled with intensive use of market products in research activities at scale. worldwide, in the fields of medicine, nutraceuticals and metabolomics.
Mass spectroscopy and NMR spectroscopy, frequently used for profiling metabolomes, are now powered by technological tools such as big data, artificial intelligence and machine learning features. In addition, most developing countries are actively seeking to strengthen the current health care infrastructure using metabolomic approaches to enable effective diagnosis and treatment of disease. Thus, propelling the growth segment of the segment during the forecast period.
The cancer segment is expected to register the fastest growing
Based on the indications, cancer segment is expected to account for the largest market share and is expected to register the fastest CAGR. This market dominance is due to the increasing number of cancer patients and therefore increases the demand for cancer treatment strategies.
According to the National Cancer Institute, under the National Institute of Health (NIH), in 2020, approximately 1.8 million new cancer patients are diagnosed in the United States, and 606,520 patients among them are expected to suffer fatal consequences.
According to the NIH, the incidence rate of new cases is approximately 442.4 cases per 100,000 males and females per year, and the death rate is approximately. 158.3 deaths per 100,000 men and women each year.
America represents the majority share of the market
Based on the region, the US market dominated the global market in terms of revenue. Due to several factors, the market is expected to continue to dominate at a stable CAGR. The large share of the US region can be attributed to the presence of important players such as Agilent, Thermofisher and others established in the regional market providing advantage and geographic presence for the home state.
The rapidly growing regional research standards in biomedical and health are continuously incorporating advanced technologies and development in research which leads to extensive use of metabolomic tools and directly stimulates adoption of market products. Additionally, the region is teeming with pharmaceutical and biotechnology companies such as Pfizer, Mylan and others, as well as CROs that are involved in growing preclinical activities involving the use of market products.
Buy now : https://straitsresearch.com/buy-now/metabolomics-market/global/
Asia-Pacific Market Expected to Record Highest Growth Rate
The Asia-Pacific market is expected to register the highest CAGR during the forecast period. The stable exponential growth rate is expected to be supported by the increasing disease burden which dramatically increases the demand for precise therapeutic measures and diagnostic techniques. Thus, the regional market is booming as these metabolomic tools are used to meet the demands.
The Asia-Pacific regions mainly include developing economies such as Japan, China, India, Korea and Australia which are constantly channeling their efforts and funding research to develop healthy and advanced healthcare facilities. The prevalence of chronic diseases such as cancer, cardiovascular disease, among others, has peaked, and more targeted efforts are planned for the management of the disease.
According to the Cancer Atlas, in 2018, 8.2 million cases of cancer were diagnosed, which corresponds to 5.2 million deaths in the region. This corresponds to about 50% of the global cancer burden. It is reported that China alone accounted for about 52% of new cancer cases and 55% of fatal cancer incidents in the region.
The main players in the regional market are Agilent, Thermo Fischer, Danaher, Merck and Cytiva which have operations throughout the region. Thus, the products in the market are likely to be readily available.
Waters Corporation (United States)
Agilent Technologies (United States)
Shimadzu Corporation (Japan)
Thermo Fisher Scientific (United States)
Danaher Corporation (United States)
Perkin Elmer (United States)
Merck KGaA (Germany)
Cytiva (formerly GE Healthcare) (United States)
Hitachi High-Technologies Corporation (Japan)
Human Metabolome Technologies, Inc. (Japan)
Bio-Rad Laboratories (United States)
DANI Instruments SpA (Italy)
Kore Technology Ltd. (UK)
Metabolomics market: segmentation
By Products and Services
High performance liquid chromatography (HPLC)
Ultra Performance Liquid Chromatography (UPLC)
Nuclear magnetic resonance spectroscopy
Surface-based mass analysis
Bioinformatics tools and services
Bioinformatics tools and database
Discovery of biomarkers
Inborn errors of metabolism
By end user
University and research institutes
Pharmaceutical and biotechnology companies
Contract research organizations
The Middle East and Africa
Email: [email protected]
Address: 825 3rd Avenue, New York, NY, United States, 10022
Phone. : +1 6464807505, +44 203 318 2846
About Us :
StraitsResearch.com is a leading market research and market intelligence organization specializing in research, analysis and advisory services, as well as providing business information and business reports. ‘marketing studies.
This version was posted on openPR.